tetano
Editor, Senior Moderator
Ann Med
. 2025 Dec;57(1):2580077.
doi: 10.1080/07853890.2025.2580077. Epub 2025 Oct 31. Long-term healthcare use of COVID-19 cases in 2020: a two-year follow-up in Stockholm, Sweden
Nicholas Baltzer[SUP] 1 2 [/SUP], Pontus Hedberg[SUP] 3 [/SUP], Sara Nordqvist Kleppe[SUP] 2 4 [/SUP], Joakim Dillner[SUP] 4 [/SUP], Anders Sönnerborg[SUP] 1 5 [/SUP], Jan Albert[SUP] 6 7 [/SUP], Kristoffer Strålin[SUP] 3 5 [/SUP], Pär Sparén[SUP] 2 [/SUP], Pontus Nauclér[SUP] 1 5 [/SUP]
Affiliations
Background: There is limited data on whether SARS-CoV-2 infections will result in increased long-term use of general healthcare, potentially impacting healthcare systems and management. Exploring this, we investigated the healthcare use of individuals with a SARS-CoV-2 infection in 2020 over a period of two years, using comprehensive medical records.
Methods: We followed a cohort of 365,354 individuals in Stockholm, Sweden, who had been tested with SARS-CoV-2 serology in 2020, for healthcare use during 2021/22. SARS-CoV-2 seropositive and seronegative individuals were matched 1:1 on age, sex, 2019 healthcare use, and date of last serology, and compared on healthcare use during 2021/22 using registry linkages. Seropositive individuals were stratified on hospitalization for COVID-19 in 2020. Individuals were compared for total healthcare use, measured as incidence rate rations (IRR), and healthcare type usage-or-not per month, measured as a difference-in-differences regression.
Results: There were 272,918 seronegative and 73,814 seropositive subjects. Incidence rate ratios (IRRs) for primary healthcare use were 1.0, 1.16, and 0.98, for all, only hospitalized, and only non-hospitalized, seropositive individuals respectively. For outpatient specialist care IRRs were 0.96, 1.31, and 0.93. For inpatient care IRRs were 0.98, 1.19, and 0.95. Healthcare type usage-or-not per month showed no substantial differences, ranging from 0.01 to -0.01 in deviation. Increased healthcare use during follow-up was restricted to the seropositive individuals hospitalized for COVID-19 in 2020.
Conclusion: There was no increase in healthcare use in the overall population from SARS-CoV-2 infections during 2020, suggesting there is no apparent need to adapt healthcare systems at scale for the COVID-19 aftermath.
Keywords: COVID-19; SARS-CoV-2; delivery of healthcare; public health; registries; serologic tests.
. 2025 Dec;57(1):2580077.
doi: 10.1080/07853890.2025.2580077. Epub 2025 Oct 31. Long-term healthcare use of COVID-19 cases in 2020: a two-year follow-up in Stockholm, Sweden
Nicholas Baltzer[SUP] 1 2 [/SUP], Pontus Hedberg[SUP] 3 [/SUP], Sara Nordqvist Kleppe[SUP] 2 4 [/SUP], Joakim Dillner[SUP] 4 [/SUP], Anders Sönnerborg[SUP] 1 5 [/SUP], Jan Albert[SUP] 6 7 [/SUP], Kristoffer Strålin[SUP] 3 5 [/SUP], Pär Sparén[SUP] 2 [/SUP], Pontus Nauclér[SUP] 1 5 [/SUP]
Affiliations
- PMID: 41169150
- DOI: 10.1080/07853890.2025.2580077
Background: There is limited data on whether SARS-CoV-2 infections will result in increased long-term use of general healthcare, potentially impacting healthcare systems and management. Exploring this, we investigated the healthcare use of individuals with a SARS-CoV-2 infection in 2020 over a period of two years, using comprehensive medical records.
Methods: We followed a cohort of 365,354 individuals in Stockholm, Sweden, who had been tested with SARS-CoV-2 serology in 2020, for healthcare use during 2021/22. SARS-CoV-2 seropositive and seronegative individuals were matched 1:1 on age, sex, 2019 healthcare use, and date of last serology, and compared on healthcare use during 2021/22 using registry linkages. Seropositive individuals were stratified on hospitalization for COVID-19 in 2020. Individuals were compared for total healthcare use, measured as incidence rate rations (IRR), and healthcare type usage-or-not per month, measured as a difference-in-differences regression.
Results: There were 272,918 seronegative and 73,814 seropositive subjects. Incidence rate ratios (IRRs) for primary healthcare use were 1.0, 1.16, and 0.98, for all, only hospitalized, and only non-hospitalized, seropositive individuals respectively. For outpatient specialist care IRRs were 0.96, 1.31, and 0.93. For inpatient care IRRs were 0.98, 1.19, and 0.95. Healthcare type usage-or-not per month showed no substantial differences, ranging from 0.01 to -0.01 in deviation. Increased healthcare use during follow-up was restricted to the seropositive individuals hospitalized for COVID-19 in 2020.
Conclusion: There was no increase in healthcare use in the overall population from SARS-CoV-2 infections during 2020, suggesting there is no apparent need to adapt healthcare systems at scale for the COVID-19 aftermath.
Keywords: COVID-19; SARS-CoV-2; delivery of healthcare; public health; registries; serologic tests.